Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 1c, Beats on Revenue

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $52.3 million versus the consensus estimate of $51.03 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
• Viking and NorthStar Earth & Space to merge on NYSE American
• L3Harris Technologies wins $96.9M Marine Corps satellite contract